CSL LIMITED (CSL) operates in the Pharmaceuticals Biotechnology & Life Sciences industry category. CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally
The most recent ex-dividend date was 11-03-2020. This dividend was $1.416 and was not franked. and was partially franked at 0%. The date paid for this dividend is 09-04-2020.
Search ASX Dividends:
CSL(CSL) has declared a UNFRANKED dividend of $1.416 per share. The dividend is franked at 0.00% therefore the franking credit is$0.00000 per share. CSL will go ex-dividend on 11-03-2020. The dividend will be paid in 48 days on 09-04-2020.